PON1 and coronary artery disorder: A variation of the copper-LDL oxidation assay, in which conjugated dienes are monitored by absorbance at 234 nm, was used to study the relationship of PON1 SNPs and arylesterase activity with the oxidation susceptibility of LDL isolated from male individuals with CAD and healthy controls [68].